Kelun-Biotech partner reports positive asthma Phase 2 trial results
September 10, 2026 | 10:34
Windward Bio reported positive interim Phase 2 POLARIS-1 trial results for asthma drug candidate SKB378/WIN378 and initiated a global Phase 3 study alongside partner Kelun-Biotech.
Mobile Version